Life Sciences & Healthcare

Online sale of medicinal products in Romania

August 2018 – The online sale of pharmaceutical products in Romania has been on the rise in recent years. This strengthening trend can be attributed to the growth of online purchases in Romania in general and to the fact that, until recently, the law...

Kinstellar advises on innovative healthcare initiative funded by the European Commission

May 2018 – Kinstellar is pleased to announce that it has served as advisor to AEGLE, an innovative project funded by the European Commission’s Horizon 2020 that focuses on improving healthcare in Europe by utilising big data analytics and establishing...

Kinstellar advises on the largest pharma transaction of 2017 in CEE

April 2018 – Kinstellar has successfully advised Penta Investments, the owner of the Dr. Max pharmacy chain operating in the Central and Eastern European region, on the acquisition of A&D Pharma, the largest pharmacy group in Romania. A&D Pharma...

Kinstellar advises on the acquisition of the largest Czech medical cannabis company

April 2018 – Kinstellar has successfully advised Canopy Growth Corporation, a world-leading diversified cannabis and hemp company, on the acquisition of the largest Czech medical cannabis company, Annabis Medical. Annabis Medical currently imports and...

Life Sciences & Healthcare in Ukraine: 2017 in Review

February 2018 – In 2017, the Ukrainian parliament adopted the long-anticipated law “On State Financial Guarantees for the Provision of Medical Services and Medicinal Products”. The new law – the first comprehensive change to the Ukrainian healthcare...

Kinstellar and The Lawyer publish report on healthcare sector opportunities in CEE

September 2017 - The healthcare industry in Central and Eastern Europe (CEE) is quickly emerging as an attractive destination for domestic and international investors. Government and individual spending on healthcare is rising, and there are vast opportunities...

The obligation to provide adequate and continuous stocks of pharmaceuticals in Romania

August 2017 – The Romanian Ministry of Health has recently issued an order on the obligation to provide adequate and continuous stocks of pharmaceuticals (the “Order”), which aims to clarify the implementation of this obligation and to provide certain...

Czech Republic: Controversial amendments aim to limit re-export of medicinal products

March 2017 – The long-awaited amendment to the Act on Medicinal Products (Act no. 378/2007 Coll., as amended) (the “Amendment”) was adopted. It (i) introduces a new legislative framework for re-export of medicinal products; (ii) imposes new measures...

Kinstellar advises TEVA on the USD 40.5 billion global acquisition of Actavis Generics

October 2016 – Kinstellar has advised its client TEVA, the world’s largest generic drug company by sales, on the Bulgarian, Czech, Hungarian and Slovak aspects of its USD 40.5 billion global acquisition of Actavis Generics, the generics division...

Kinstellar advises shareholders of Quinta-Analytica on the acquisition by Genesis Private Equity Fund

June 2016 - Kinstellar has successfully advised the shareholders of the Czech company QUINTA-ANALYTICA, an established provider of R&D and regulatory services for the pharmaceutical, biotechnology and generic drug industries, on the sale of their...